{"id":"W4296628505","doi":"10.1016/j.jacig.2022.07.009","title":"Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities","year":2022,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology Global","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Toronto","funders":"National Health and Medical Research Council; Nutricia North America; National Institute of Allergy and Infectious Diseases; Medical Research Council; Financial Markets Foundation for Children; National Institutes of Health; Regeneron Pharmaceuticals; AstraZeneca; Aimmune Therapeutics; CSL Behring; Danone; Sanofi; Genentech; Food Allergy Research and Education; Pfizer","keywords":"Medicine; Placebo; Tolerability; Atopic dermatitis; Peanut allergy; Concomitant; Allergy; Adverse effect; Randomized controlled trial; Food allergy; Anaphylaxis; Asthma; Internal medicine; Subgroup analysis; Dermatology; Immunology; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000967768,0.0002351905,0.0008791127,0.0001939635,0.0002208307,0.0003593997,0.0001571221,0.0003129844,0.0009006517],"category_scores_gemma":[0.001746871,0.00009105758,0.001004521,0.0002582107,0.0001550171,0.0002668081,0.0001924507,0.0005437194,0.00008726893],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002949763,"about_ca_system_score_gemma":0.0003305625,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003922444,"about_ca_topic_score_gemma":0.0008441987,"domain_scores_codex":[0.9995918,0.0001807518,0.00005820743,0.00006239995,0.00006251431,0.0000443952],"domain_scores_gemma":[0.9990633,0.0003640335,0.0003531136,0.00004039137,0.000049111,0.0001300967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2437941,0.002683243,0.4172758,0.002873845,0.00440223,0.0009687681,0.0003165121,0.001662635,0.01721405,0.0003188378,0.001404757,0.3070852],"study_design_scores_gemma":[0.02486231,0.08898821,0.868022,0.0005043433,0.004177106,0.002566002,0.0002736109,0.001673516,0.00406156,0.0003598582,0.004477121,0.00003447612],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762906,0.02172623,0.0001344438,0.0001805312,0.00003123901,0.00008790406,0.0002438759,0.000009964621,0.001295223],"genre_scores_gemma":[0.9972194,0.002099152,0.0001701671,0.0001052609,0.00005002454,0.00004367665,0.0002028322,0.000001281025,0.0001080743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000967768,"threshold_uncertainty_score":0.005118132,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01569641041579029,"score_gpt":0.3115846625116886,"score_spread":0.2958882520958984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}